Berend Snijder

Faculty Professor

Berend Snijder is a Faculty Professor at the Botnar Institute of Immune Engineering. He is a group leader at the Swiss Institute of Bioinformatics and the Comprehensive Cancer Center Zurich, and was previously Assistant Professor at the Institute of Molecular Systems Biology at the ETH Zurich. Berend’s research focuses on the systematic functional and multi-omic profiling of human tissues in health and disease, with strong bioinformatics and clinical/translational focus. He is a leading figure in the field of functional precision medicine. Berend has co-founded three spinoff companies, including Allcyte (acquired by Exscientia, now Recursion), Prevision Medicine, and Graph Therapeutics.